Cargando…
GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin Pathway
BACKGROUND & AIMS: Transforming growth factor (TGF-β)–induced activation of quiescent hepatic stellate cells (HSCs) and their transformation to myofibroblasts is a key event in liver fibrosis and portal hypertension. GIPC (also referred to as synectin) is a downstream signal activation molecule...
Autores principales: | Yaqoob, Usman, Luo, Fanghong, Greuter, Thomas, Jalan Sakrikar, Nidhi, Sehrawat, Tejasav S., Lu, Jianwen, Hu, Xiao, Gao, Jinhang, Kostallari, Enis, Chen, Jingbiao, Arab, Juan Pablo, Martin-Mateos, Rosa, Cao, Sheng, Shah, Vijay H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399184/ https://www.ncbi.nlm.nih.gov/pubmed/32447051 http://dx.doi.org/10.1016/j.jcmgh.2020.05.005 |
Ejemplares similares
-
Editorial: Hepatic immune response underlying liver cirrhosis and portal hypertension
por: Guo, Yangkun, et al.
Publicado: (2023) -
Editorial: Community series in hepatic immune response underlying liver cirrhosis and portal hypertension, volume II
por: Lan, Tian, et al.
Publicado: (2023) -
Editorial: Chronic Liver Disease: New Targets and New Mechanisms, Volume II
por: Jerez, Sofia, et al.
Publicado: (2023) -
Editorial: Chronic Liver Disease: New Targets and New Mechanisms
por: Ye, Yanting, et al.
Publicado: (2022) -
Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis
por: Martin-Mateos, Rosa, et al.
Publicado: (2018)